I'm considering investing in CRISPR stocks, but I'm not sure if it's a worthwhile investment. I've heard about the potential of gene editing technology, but I want to know if CRISPR stocks are a good buy at this point in time.
            
            
            
            
            
            
           
          
          
            5 answers
            
            
  
    
    Maria
    Sat Nov 09 2024
   
  
    CRSP stock forecast has garnered much attention from investors. According to analysts' average price target, Crispr Therapeutics AG has a potential upside of 36.52%. This prediction offers a glimpse into the potential growth of the company's stock in the future.
  
  
 
            
            
  
    
    Leonardo
    Sat Nov 09 2024
   
  
    In terms of analyst ratings, Crispr Therapeutics AG has received a consensus rating of Moderate Buy. This rating is compiled based on various factors, including the company's financial performance, market potential, and competitive landscape.
  
  
 
            
            
  
    
    Silvia
    Sat Nov 09 2024
   
  
    Breaking down the ratings further, Crispr Therapeutics AG has received 8 buy ratings from analysts. These ratings indicate that analysts believe the company's stock has a strong potential for growth and is worth investing in.
  
  
 
            
            
  
    
    Bianca
    Fri Nov 08 2024
   
  
    Additionally, the company has also received 5 hold ratings. These ratings suggest that analysts believe the company's stock will remain stable in the near future and may not experience significant growth or decline.
  
  
 
            
            
  
    
    Riccardo
    Fri Nov 08 2024
   
  
    On the other hand, Crispr Therapeutics AG has also received 2 sell ratings. These ratings indicate that analysts believe the company's stock may decline in the future and is not a good investment opportunity at this time.